Peptide record

TPDB11307

Palustrin - Ca Antibacterial Anticancer Antifungal Toxicity standard
31 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11307
Palustrin - Ca
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia AntiCP 2.0 CancerPPD 2.0 dbACP iACP-DRLF Antifungipept CAFPdb dbAMP ToxinPred 3.0
standard
No
A 31-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, AntiCP 2.0, and other sources, with an available 3D structural model.
Sequence
GFLDIIKDTGKEFAVKILNNLKCKLAGGCPP
Physicochemical Analysis
C150H248N38O41S2
RQHMSWY
K
3303.97
9.02
5
3
12
+2
5.17
0.148
103.87
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
3.78
5
Residue Composition
number
2
A
0
R
2
N
2
D
2
C
1
E
0
Q
4
G
0
H
3
I
4
L
5
K
0
M
2
F
2
P
0
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 2 D: 2 C: 2 E: 1 Q: 0 G: 4 H: 0 I: 3 L: 4 K: 5 M: 0 F: 2 P: 2 S: 0 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
31
C150H248N38O41S2
3303.97
9.02
+2
5.17
0.148
Free
L
Linear
Free
Host Defence Peptide
Lithobates catesbeianus
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
30 µg/mL

Target

L. monocytogenes ATCC 54004

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
active against L. monocytogenes ATCC 54004 (MIC 30 ug/ml), S. aureus ATCC 25923 (MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis
Evidence 2 Activity

Activity

MIC
Antibacterial
7.8 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP

Other

active against L. monocytogenes ATCC 54004 (MIC 30 ug/ml), S. aureus ATCC 25923 (MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis ADB403 (MIC 30 ug/ml), P. aeruginosa A
Evidence 3 Activity

Activity

MIC
Antibacterial
31.25 µg/mL

Target

S. suis 2 CVCC 606

Source & Reference

dbAMP

Other

against L. monocytogenes ATCC 54004 (MIC 30 ug/ml), S. aureus ATCC 25923 (MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis ADB403 (MIC 30 ug/ml), P. aeruginosa ATCC 227853 or ATCC 227853 (MIC 30-60 u
Evidence 4 Activity

Activity

MIC
Antibacterial
30 µg/mL

Target

B. subtilis ADB403

Source & Reference

dbAMP

Other

IC 30 ug/ml), S. aureus ATCC 25923 (MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis ADB403 (MIC 30 ug/ml), P. aeruginosa ATCC 227853 or ATCC 227853 (MIC 30-60 ug/ml).
Evidence 5 Activity

Activity

MIC
Antibacterial
30-60 µg/mL

Target

Pseudomonas aeruginosa ATCC 227853 or ATCC 227853

Source & Reference

dbAMP

Other

(MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis ADB403 (MIC 30 ug/ml), P. aeruginosa ATCC 227853 or ATCC 227853 (MIC 30-60 ug/ml).
Evidence 6 Activity

Activity

IC50
IC50 = 0.951 µg/ml
Anticancer
0.951 µg/mL

Target

Gastric Cancer
SGC-7901
Stomach

Assay & Model

Not Available
Not Available

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2021

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 7 Activity

Activity

MIC
Antifungal
30 µg/mL

Target

L. monocytogenes ATCC 54004

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
active against L. monocytogenes ATCC 54004 (MIC 30 ug/ml), S. aureus ATCC 25923 (MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis
Evidence 8 Activity

Activity

MIC
Antifungal
7.8 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP CAFPdb Antifungipept

Other

active against L. monocytogenes ATCC 54004 (MIC 30 ug/ml), S. aureus ATCC 25923 (MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis ADB403 (MIC 30 ug/ml), P. aeruginosa A
Evidence 9 Activity

Activity

MIC
Antifungal
31.25 µg/mL

Target

S. suis 2 CVCC 606

Source & Reference

dbAMP CAFPdb Antifungipept

Other

against L. monocytogenes ATCC 54004 (MIC 30 ug/ml), S. aureus ATCC 25923 (MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis ADB403 (MIC 30 ug/ml), P. aeruginosa ATCC 227853 or ATCC 227853 (MIC 30-60 u
Evidence 10 Activity

Activity

MIC
Antifungal
30 µg/mL

Target

B. subtilis ADB403

Source & Reference

dbAMP CAFPdb Antifungipept

Other

IC 30 ug/ml), S. aureus ATCC 25923 (MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis ADB403 (MIC 30 ug/ml), P. aeruginosa ATCC 227853 or ATCC 227853 (MIC 30-60 ug/ml).
Evidence 11 Activity

Activity

MIC
Antifungal
30-60 µg/mL

Target

Pseudomonas aeruginosa ATCC 227853 or ATCC 227853

Source & Reference

dbAMP CAFPdb Antifungipept

Other

(MIC 7.8 ug/ml), S. suis 2 CVCC 606 (MIC 31.25 ug/ml), B. subtilis ADB403 (MIC 30 ug/ml), P. aeruginosa ATCC 227853 or ATCC 227853 (MIC 30-60 ug/ml).
Evidence 12 Activity

Activity

0% Hemolysis
Toxicity
250 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 250 | µg/mL | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
Effects of Two Novel Peptides from Skin of Lithobates Catesbeianus on Tumor Cell Morphology and Proliferation | Molecular Cloning - Selected Applications in Medicine and Biology | 2011